Rxmd Pharmaceutical Physicians Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -18.30%
- Profit Growth -92.01%
- Ebitda -23.77%
- Net Worth 35.08%
- Total Assets 30.10%
About Rxmd Pharmaceutical Physicians
Rxmd Pharmaceutical Physicians Private Limited (RPPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 May 2002 and has a history of 22 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sumitra Niranjan and Viswanathan Niranjan serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TN2002PTC049005
- Company No.
049005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Rxmd Pharmaceutical Physicians?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumitra Niranjan  | Managing Director | 28-May-2002 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viswanathan Niranjan  | Director | 28-May-2002 | Current |
Financial Performance of Rxmd Pharmaceutical Physicians.
Rxmd Pharmaceutical Physicians Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 18.3% decrease. The company also saw a substantial fall in profitability, with a 92.01% decrease in profit. The company's net worth Soared by an impressive increase of 35.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rxmd Pharmaceutical Physicians?
In 2017, Rxmd Pharmaceutical Physicians had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gxp Consultants Private LimitedSumitra Niranjan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rxmd Pharmaceutical Physicians?
Unlock and access historical data on people associated with Rxmd Pharmaceutical Physicians, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rxmd Pharmaceutical Physicians, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rxmd Pharmaceutical Physicians's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.